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Abstract
A dysfunction of retinoid hippocampal signaling pathway has been involved in the appearance of affective and cognitive
disorders. However, the underlying neurobiological mechanisms remain unknown. Hippocampal granule neurons are
generated throughout life and are involved in emotion and memory. Here, we investigated the effects of vitamin A
deficiency (VAD) on neurogenesis and memory and the ability of retinoic acid (RA) treatment to prevent VAD-induced
impairments. Adult retinoid-deficient rats were generated by a vitamin A-free diet from weaning in order to allow a normal
development. The effects of VAD and/or RA administration were examined on hippocampal neurogenesis, retinoid target
genes such as neurotrophin receptors and spatial reference memory measured in the water maze. Long-term VAD
decreased neurogenesis and led to memory deficits. More importantly, these effects were reversed by 4 weeks of RA
treatment. These beneficial effects may be in part related to an up-regulation of retinoid-mediated molecular events, such
as the expression of the neurotrophin receptor TrkA. We have demonstrated for the first time that the effect of vitamin A
deficient diet on the level of hippoccampal neurogenesis is reversible and that RA treatment is important for the
maintenance of the hippocampal plasticity and function.
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Introduction
Vitamin A deficiency (VAD), leading to retinoic acid (RA)
hyposignaling, represents a major public health problem and is
estimated to affect 200 million children and adults in many
countries [1,2]. A disruption of retinoid signaling pathway has
been involved in the pathophysiology of affective disorders,
schizophrenia and late-onset Alzeimer’s disease [2–8]. Animals’
studies have shown that vitamin A and RA play a key role during
brain development [9–12], and during adulthood, retinoids have
been shown to modulate emotional and memory functions [2,13].
The effects of retinoids on memory have been proposed to be
mediated, at least in part, by an alteration of hippocampal
plasticity. Indeed, retinoids are required for long term synaptic
plasticity in the hippocampal formation (HF) [14,15], a key
structure in memory processing [16,17]. Furthermore, vitamin A
deficiency impairs spatial memory [18,19]. In aged subjects, the
naturally occurring hypoactivity of the retinoid signaling pathway
also induces spatial memory and hippocampal long term
potentiation deficits, which are alleviated by the normalization
of brain retinoid signaling with RA treatment or nutritional
vitamin A supplementation [20,21]. Despite these striking
relationships between retinoid signaling and memory, the
mechanisms by which hippocampal retinoid hyposignaling
influence learning abilities remain largely unknown.
The dentate gyrus (DG) of the HF is one of the areas where
neurons are generated throughout the lifespan [22–24]. The newly
born cells express neuronal markers, emit axons, receive synaptic
inputs; in addition, their electrophysiological properties are very
similar to those of mature dentate granule neurons. Neurogenesis
has been hypothesized to play an important role in spatial memory
[23,25,26]. Recently, its specific contribution to spatial memory
evaluated in the water maze has been evidenced using genetic
approaches [27,28]. The ability of RA to promote in vitro
neurogenesis [29–31] suggested that activation of retinoid
signaling constitutes a therapeutic strategy to increase adult
hippocampal neurogenesis and consequently hippocampal-depen-
dent memory [3,32]. However, contrasting results have been
obtained in vivo. Long term exposure to RA decreases hippocampal
neurogenesis [33], whereas maternal VAD disrupts irreversibly
adult hippocampal neurogenesis in the adult offspring [34].
Consequently, the influence of retinoid signaling on this novel
form of structural plasticity still remains controversial.
Here, we tested the hypothesis that retinoid hyposignaling
decreases adult hippocampal neurogenesis and spatial memory. In
order to address this issue, retinoid-deficient rats have been
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approach enables normal embryogenesis and postnatal develop-
ment, does not altered mother-infant interaction while permitting
controlled vitamin A depletion in the adult rat. We further
examined whether these effects could be reversed by RA treatment
in adulthood. Finally, we investigated possible retinoid target genes
as neurotrophin receptors that could be involved in these
processes.We have demonstrated that both hippocampal neuro-
genesis and spatial memory can be rescued by RA treatment in
vitamin A deficient rats.
Materials and Methods
Animals
Weaning male Wistar rats (3-week old) were purchased from
Harlan (Gannat, France). They were housed two per cage in a
room with a constant airflow system, controlled temperature (21–
23uC), and a 12 h light/dark cycle. The rats were given ad libitum
access to food and water and were randomly divided into two
experimental groups. One group (n=55) received a vitamin A-free
diet (Laboratorio Piccionni, Italy), whereas the second group
(n=52) was fed with a control diet containing 5 IU retinol/g
(INRA, Jouy en Josas). All animals were individually housed from
one week prior to the beginning of RA treatment until sacrifice. All
experiments were performed in accordance with the European
Communities Council Directives (86/609/EEC) and the French
national Committee (87/848) recommendations.
Treatments
RA injections. Half the control and VAD rats were injected
daily with RA (150 mgo fall-trans-RA/kg, Sigma, France). RA was
dissolved in a mixture (vehicle) containing polyethyleneglycol-
NaCl-ethanol (70:20:10, by vol.). This dose of RA was shown to be
effective in reversing age-related hypoexpression of brain signaling
and its associated memory impairment [20]. The other half of the
animals was treated daily with vehicle only.
5-Bromo-29-deoxyuridine (BrdU) injections. In order to
label the newly born cells and examine hippocampal cell survival,
BrdU, a thymidine analogue incorporated into genetic material
during synthetic DNA phase of mitotic division, was used. Rats
received a daily intraperitoneal injection of BrdU (50 mg/kg,
Sigma, France), dissolved in phosphate buffer (0.1 M, pH 8.4),
during the 4 consecutive days beginning 4 days after the first
injection of RA.
Immunohistochemistry
Rats were anesthetized with pentobarbital (100 ml per 100 g)
and perfused transcardially with 200 ml of phosphate-buffered
saline (PBS, pH 7.4) containing heparin, followed by 300 ml of
4% paraformaldehyde. After 1 week postfixation period in
paraformaldehyde, 50 mm frontal sections were cut on a
vibratome (Leica). Free-floating sections were processed with a
standard immunohistochemical procedure [35]. A one–in-ten
section was treated for KI-67 immunoreactivity using a mouse
anti-KI-67 monoclonal antibody (1:200, Novocastra, Newcastle,
U.K.) or for double-cortin (DCX) immunoreactivity using a goat
polyclonal antibody (1:1000, Santa Cruz Biotechnology, Santa
Cruz, California). Secondary antibodies were biotinylated horse
anti-mouse and donkey anti-goat (1:200, AbCys; 1:200, Amer-
sham). For BrdU labeling, adjacent sections were treated with 2N
HCl to denature DNA (30 min at 37uC) and then washed in
phosphate buffer. Sections were incubated with a mouse
monoclonal anti-BrdU antibody (1:200, Dako) followed by the
biotinylated horse anti-mouse antibody (1:200, AbCys). Sections
were processed in parallel, and immunoreactivities were visualized
by the biotin-streptavidin technique (ABC kit, Dako) by using 3,39-
diaminobenzidine as chromogen.
The number of immunoreactive (IR) cells in the left DG was
estimated by using a modified version of the optical fractionator
method with a systematic random sampling of every 10 sections
along the rostrocaudal axis of the DG. On each section, IR cells in
the granular and subgranular layers of the DG were counted with
a 1006microscope objective [35]. All results are expressed as the
total number of cells in the whole DG.
To analyze the phenotype of BrdU labeled cells, 8 rats per
group were randomly selected. One in ten sections obtained from
the second experiment was incubated with rat anti-BrdU
monoclonal antibodies (1:500, Servibio), which were revealed by
using CY3-labeled anti-rat IgG antibodies (1:1000, Interchim).
Sections were then incubated with mouse monoclonal anti-NeuN
antibodies (1:1000, Euromedex), and bound anti-NeuN monoclo-
nal antibodies were visualized with an Alexa 488 goat anti-rabbit
IgG (1:1000, Interchim). The percentage of BrdU-labeled cells
that expressed NeuN was determined throughout the DG by using
a confocal microscope with HeNe and Argon lasers (Nikon PCM
2000). All BrdU double labeled cells were examined, and sections
were optically sliced in the Z plane by using a 1 mm interval. Cells
were rotated in orthogonal planes to verify double labeling.
Behavioral testing
Rats were tested in a Morris water maze (180 cm diameter,
60 cm high) filled with water (22uC) made opaque by addition of
white paint. An escape platform was hidden 2 cm below the
surface of the water in a fixed location in one of four quadrants
halfway between the wall and the middle of the pool. Before the
start of the training, animals were habituated to the pool without a
platform for 1 min/day for 2 days. During training, animals were
required to locate the submerged platform by using distal
extramaze cues. They were tested for four trials per day (90 s
with an intertrial interval of 60 s, beginning from three different
start points randomized every day) for 7 consecutive days. The
distance covered to find the platform and the time to reach the
platform were measured with a computerized tracking system
(Videotrack, Viewpoint, Lyon, France). After the last training day,
on day 8, animals were placed for 60 s in the pool without the
platform (probe test). Performance was evaluated by the
percentage of time spent in the quadrant where platform was
located during training (target quadrant). Finally, in order to
control for visual acuity deficits, the hidden platform was replaced
by a visible platform located in the opposite quadrant, and animals
were tested for four trials (90 s) over one day. One control rat
treated with vehicle was excluded from the experiment due to
failure to search for the platform during the acquisition phase
(tigmotaxis).
Real-Time PCR analysis of neurotrophin receptor
expression
Rats were sacrificed by decapitation, and each hippocampus
was rapidly removed and stored at 280uC in order to measure
neurotrophin receptor expression. Extraction of RNA was
conducted using an extraction kit (TRIzol reagent, Invitrogen,
France) according to the manufacturer’s instructions. The quality
and the concentration of RNA were determined by spectropho-
tometry. Then, the integrity of the purified RNA was verified
using the RNA 6000 Pico LabChip kit in combination with the
2100 bioanalyser (Agilent Technologies). Using OligodT and
random primers (Promega, France), cDNA was synthesized with
ImPromII reverse transcriptase (Promega, France). Briefly, 1 mgo f
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(Roche, France) was incubated at 37uC. Then, OligodT plus
random primers were added for incubation at 70uC. The reverse
transcriptase reaction was performed at 42uC for 60 min in a final
volume of 20 ml. The polymerase chain reaction (PCR) was
performed in a LightCycler system (Roche Diagnostics, Germany).
The forward and reverse primer sequences for each gene are in
Table 1. To detect target genes amplification products, a
LightCycler DNA Master SYBR Green I kit was used according
to the manufacturer’s instructions. PCR was performed in micro-
capillary tubes in a final volume of 20 ml, containing 16LC-DNA
Master Green I mix, 4 mM MgCl2, 0.5 mM of each primer and
4 ml cDNA. The specificity and the identity of the amplified
products was verified as follows: (1) melting curve analysis showed
a single melting peak after amplification, and (2) amplified
products for each gene were verified by sequencing with the Big
Dye Terminator v1.1. (Applied Biosystems) and analyzed on a ABI
3130 sequencer (Applied Biosystems).
Quantification data were analyzed using the LightCycler Relative
Quantification Software (Roche, Germany). Due to the fact that
target and reference genes have different sequences and amplicon
lengths,differentPCRefficienciescouldbefound.Forthisreason,the
software provides a calibrator-normalized relative quantification
including a PCR efficiency correction [36]. In our case, the calibrator
was chosen among the control rats. Results are expressed as the
target/reference ratio divided by the target/reference ratio of the
calibrator. Two housekeeping genes, PPIB and BMG, were used to
quantify the expression of each gene (i.e TrkA, TrkB) in order to
avoid possible errors related to our practice of using only one
reference gene for normalization [37]. Thus, the expression of these
housekeeping genes, which is the same in all groups of animals, has
been shown to be unaffected by our experimental conditions. The
results presented are normalized in comparison to PPIB.
Measurement of serum retinol concentration
Blood was collected and spun at 3000 rpm for 15 minutes. The
supernatant was removed and snap frozen on dry ice. Serum
retinol was assayed by HPLC according to a previously described
method [38].
Experimental design
First experiment: effects of 11 weeks of VAD and one
week RA treatment (between the 10
th and 11
th week of VAD)
on neurogenesis. We examined the effects of 11 weeks of a
vitamin A-free diet on cell proliferation and neurogenesis in the
DG. In order to study the role of RA, control and VAD rats were
injected with RA or vehicle daily for one week during the 10
th
week of VAD. All groups (Control+vehicle, n=8; Control+RA,
n=8; VAD+vehicle, n=8; VAD+RA n=9) were sacrificed at the
11
th week of VAD (Fig. 1A). Cell proliferation was examined using
an endogenous marker of the cell cycle, KI-67. DCX was used as a
surrogate of neurogenesis.
Second experiment: effects of 14 weeks of VAD and four
weeks RA treatment (between the 10
th and 14
th week of
VAD) on cell survival and differentiation. In a subsequent
experiment, we examined the effects of VAD and RA treatment
on cell survival and differentiation. From the 10
th week of VAD,
animals were injected with RA or vehicle daily for four weeks
(Control+vehicle, n=9; Control+RA, n=8; VAD+vehicle, n=9;
VAD+RA n=9). Four days after the beginning of RA treatment,
all groups were injected with BrdU for 4 days. Rats were allowed
to survive for another three weeks after the last injection of BrdU
and continued treatment in their respective experimental
conditions (Fig. 1B). In order to obtain more information about
adult neurogenesis independent of BrdU, we studied the
expression of DCX. Cell proliferation was also studied using the
endogenous marker, KI-67.
Third experiment: effects of 14 weeks of VAD and four
weeks RA treatment (between the 10
th and 14
th week of
VAD) on spatial learning and memory and hippocampal
neurotrophin receptor expression. We then examined the
influence of VAD and RA treatment on spatial memory. From the
10
th week of VAD, animals were injected with RA or vehicle
(Control+vehicle, n=9; Control+RA, n=10; VAD+vehicle,
n=10; VAD+RA, n=10). Two weeks later, animals were tested
in a watermaze task. All groups were sacrificed one week after the
completion of behavioral testing to analyze neurotrophin receptor
expression (Fig. 1C).
Statistical analysis
All results were expressed as mean6SEM. Data were submitted
to analyses of variance. When appropriate, post-hoc comparisons
were performed using the Fisher PLSD test. Whenever two groups
were compared, an unpaired t-test was used.
Results
Status of vitamin A deficiency
Analysis of serum retinol levels was performed after 11 or 14
weeks of VAD in order to confirm the status of VAD rats. Serum
retinol concentration was significantly diminished by 11 weeks of
VAD [Control:1.0860.07 mmol/l; VAD:0.0760.006 mmol/l,
t(14)=210.45, p,0.0001]. However, a whole vitamin A depletion
was produced by 14 weeks of VAD, retinol being undetectable in
the VAD serum at that time [Control:1.4660.08 mmol/l;
VAD:,0.01 mmol/l].
Effects of vitamin A deficiency and RA treatment on
hippocampal neurogenesis
The influence of VAD and RA treatment were examined on
hippocampal cell proliferation and neurogenesis (experiment 1).
Cell proliferation was measured following 11 weeks of VAD, using
an endogenous marker of cell cycle, KI-67 [39]. KI-67-labeled
cells were located within the subgranular zone and were isolated or
grouped in clusters (Fig. 2A). Quantitative analysis revealed that
neither a control diet with or without RA injections, nor a VAD
diet alone had an effect on cell proliferation (Fig. 3A). In contrast,
the number of KI-67 expressing cells was increased by ,35% in
Table 1. Primers used for Light Cycler RT-PCR.
Gene
name Nucleotide sequence
Product
lenght (bp)
PPIB F: 59-GTTCTGGAAGGCATGGATGT-39
R: 59-TCCCCGAGGCTCTCTCTACT-39
153
BMG F: 59-GCCCAACTTCCTCAACTGCTACG-39
R: 59-GCATATACATCGGTCTCGGTGGG-39
180
TrkA F: 59-ACTGGGTGGCAGTTCTCTTTCC-39
R: 59-TCCTGGCGCTTGATATGGTG-39
117
TrkB F: 59-TTCCGGTGGTTTTAGCCTGTG-39
R: 59-TCACTCCTGCTGTGCTTTATGG-39
122
Sequences are shown for foward (F) and reverse (R) primers. PPIB: peptidylprolyl
isomerase B (cyclophilin B); BMG: b2-microglobulin, TrkA: tropomyosin-related
kinase A; TrkB: tropomyosin-related kinase B.
doi:10.1371/journal.pone.0003487.t001
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[F(3,29)=3.66,p,0.05;C=C+RA=VAD,VAD+RA at least
p,0.05]. We also determined whether 11 weeks of VAD and 1
week of RA treatment influence neurogenesis by using double-
cortin (DCX), a microtubule-associated phosphoprotein, as a
surrogate [40]. DCX-IR cells were located in the deepest region of
granule cell layer (gcl) at the interface of the hilus. Their dendrites
radiated into the molecular layer (Fig. 2B). A quantitative analysis
revealed that 11 weeks of VAD or RA treatment has no effect on
the number of newly generated neurons [Fig. 3B,
F(3,29)=1.51,p=0.23].
The aim of the second study was twofold: (1) to determine
whether cell proliferation and neurogenesis were influenced by a
longer vitamin A deficient diet and RA treatment, and (2) to
determine whether the survival and differentiation of cells born
during the 10
th week of VAD were influenced by subsequent VAD
and/or RA treatment. To address this issue, animals were injected
with BrdU 10 weeks after the beginning of VAD and allowed to
survive for 3 additional weeks.
As expected, after 14 weeks, VAD decreased cell proliferation
by ,32%. This effect was completely overcompensated by RA
treatment, which by itself did not have any effect in control
animals [Fig. 4A, F(3,31)=11.95,p,0.0001 with VAD,C=-
C+RA,VAD+RA at least p,0.05]. We also found that the
number of DCX expressing cells was decreased in VAD rats by
,25%, and this effect was overcompensated by RA administration
[Fig. 4B; F(3,31)=11.40,p,0.0001 with VAD,C=C+RA,VA-
D+RA at least p,0.05].
When examining the effect of VAD and/or RA on cell survival,we
found that most of the 3-week-old surviving BrdU-IR cells were
i so la t e d ,ro u nd ,la rg eandl o c ate dw i thi ntheg cl(F i g.2 C) .A ss h o w ni n
Fig. 4C, the number of BrdU-IR cells was not affected by a control
diet with or without RA injections nor a VAD diet alone. In contrast,
the number of BrdU labeled cells in VAD rats injected with RA was
greater than that measured in the other groups [F(3,31)=3.46,p,0.05
with C=VAD=C+RA,VAD+RA at least p,0.05].
The phenotype of newly born cells labeled with BrdU was
determined using NeuN, a neuronal marker. The percentage of
BrdU/NeuN double stained cells located in the gcl (Fig. 2D) did
not differ between the four experimental groups [C:92.961.4,
C+RA:91.461.4, VAD:89.862.3, VAD+RA:94.561.8;
F(3,28)=1.23,p=0.31]. The ratio of BrdU-IR cells colabeled with
NeuN was multiplied by the total number of BrdU-labeled cells to
give an estimate of the total number of BrdU-labeled neurons. The
extrapolated total number of 3-week-old, BrdU-labeled neurons in
VAD rats receiving RA injections was higher than that of the other
groups [Fig. 4D, F(3,28)=5.162,p,0.01; with C=VAD=
C+RA,VAD+RA at least p,0.05]. We then calculated the rate
of cell survival by comparing, within each animal, the number of
3-week-old BrdU-IR cells to the number of proliferation KI67
Figure 1. Experimental protocols. Weaning rats (3 weeks old) were submitted to 11 weeks or 14 weeks of vitamin A deficiency (VAD). The first
two experiments were intended to study the effects of VAD and/or RA administration on hippocampal neurogenesis. The third experiment was
designed to study the effects of VAD and/or RA administration on spatial memory and hippocampal neurotrophic receptor expression. The arrows
and the grey bars indicate VAD and RA treatment, respectively.
doi:10.1371/journal.pone.0003487.g001
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groups [C:0.5760.07, C+RA:0.7560.10, VAD:0.7260.10, VA-
D+RA:0.7360.11, F(3,31)=0.64, p=0.59].
Thus, altogether these results showed that VAD decreases cell
proliferation and neurogenesis; these effects are reversed by 4
weeks RA treatment. In contrast, cell survival and cell differen-
tiation are not influenced by VAD and/or RA treatment.
Effects of vitamin A deficiency and RA treatment on
spatial learning and memory
The previous experiments suggested that neurogenesis, as
evaluated with DCX, was impaired after 11 weeks of VAD.
Indeed, immature neurons expressed DCX until they are 2–3
weeks old [40,41]. The 3 weeks delay necessary to observe a
decrease in DCX expression indicates that reduction in cell
proliferation occurred between the 11
th and the 12
th week of the
VAD. For this reason, animals were trained in the water maze
between the 12
th and 13
th week (Fig. 1C). In the water maze,
animals are required to locate a hidden platform using the spatial
cues available in the testing room. Control animals and animals
treated with RA learned this task as shown by the progressive
decrease in the distance covered to reach the hidden platform over
the seven days of training (Fig. 5A). Memory impairment was
observed in VAD rats that traveled a higher distance to find the
platform. This deficit was reversed in VAD rats receiving RA
Figure 2. Illustration of neurogenesis in the dentate gyrus. Examples of : (A) Ki67-IR cells (B) DCX-IR cells and (C) 3-week-old BrdU-IR cells. (D)
Three dimensional reconstruction of a z series along the y-z axis (narrow right panel) and x-z axis (narrow bottom panel) showing that a 3-week-old
newly born cell (red) is double stained with the neuronal marker NeuN (green). Scale bar : A–C,5 0mm. gcl=granule cell layer.
doi:10.1371/journal.pone.0003487.g002
Figure 3. Effects of 11 weeks of vitamin A deficiency and RA treatment on hippocampal neurogenesis. Total number of: (A) KI-67-IR
cells and (B) DCX-IR cells in the DG after 11 weeks of VAD. VAD for 11 weeks does not affect cell proliferation or the number of immature DCX
neurons.*p,0.05, **p,0.01 when compared to VAD+RA.
doi:10.1371/journal.pone.0003487.g003
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control rats [F(3,35)=4.075,p,0.05 with VAD.C=C+RA=VA-
D+RA at least p,0.05]. Similar results were obtained for the
latency to find the hidden platform [Fig. 5B, F(3,35)=3.12,p,0.05
with VAD.C=C+RA=VAD+RA at least p,0.05]. VAD rats
exhibited normal motor functioning, as evidenced by the lack of a
significant difference in swimming speed [data not shown,
F(3,35)=1.32,p=0.28].
On day 8, memory for the platform location was tested using a
probe test. The time spent in the quadrant previously containing
the platform was measured. VAD rats failed to display a memory
for the platform location, as indicated by a percent time swimming
in the target quadrant around the chance level (25%, Fig. 5C).
This deficit was reversed by RA administration
[F(3,35)=8.076,p,0.001; with VAD,C=C+RA=VAD+RA at
least p,0.01]. After the probe trial on day 9, animals were trained
to find a visible platform. The distance traveled
[F(3,35)=3.35,p=0.093] and the latency [F(3,35)=1.85,p=0.15]
to find a visible platform were identical for the different groups.
These results indicate that learning differences were not due to
differences in motor or visual capabilities, thigmotaxic behavior, or
more generally to differences in health status.
Taken together, these results showed that VAD induced spatial
memory deficits in the water maze that could be reversed by RA
administration.
Effects of vitamin A deficiency and RA treatment on
hippocampal neurotrophin receptor expression
The ability of RA to promote neurogenesis and improve memory
abilities in VAD rats could be in part mediated by activation of
neurogenesis-related gene expression via neurotrophin receptors,
which are known to be regulated by RA in vitro [30,42–46]. To
uncover the possible mechanisms involved in the effect of VAD and
RA treatment on neurogenesis, animals were sacrificed one week
after the behavioral experiment (Fig. 1c). As seen in Fig. 6A,
quantitative analysis of hippocampal TrkA mRNA expression
indicated differences between groups [F(3,34)=3.07,p,0.05]. In-
deed, we observed that VAD tended to reduce hippocampal TrkA
mRNA expression compared to control rats (36%, p=0.09), which
is fully upregulated by RA treatment (VAD,VAD+RA, p=0.01).
Figure 4. Effects of 14 weeks of vitamin A deficiency and RA treatment on hippocampal neurogenesis. Total number of : (A) KI-67-IR
cells, (B) DCX-IR cells, (C) 3 weeks old BrdU-IR cells and D) the extrapolated number of newly born neurons after 14 weeks of VAD. VAD for 14 weeks
decreases cell proliferation and neurogenesis, an effect reversed by 4 weeks RA treatment.*p,0.05; ***p,0.001 when compared to VAD+RA,
uup,0.01 when compared to C.
doi:10.1371/journal.pone.0003487.g004
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mRNA expression. When considering hippocampal levels of TrkB
mRNAs, no significant variation was observed between groups
[Fig. 6B, F(3,34)=0.98, p=0.41].
These data suggested that RA signaling may regulate TrkA
transcription in the hippocampus that could be an important
regulatory mechanism involved in the restoration of adult
neurogenesis and spatial memory in VAD rats.
Discussion
The results of the present experiments show that 14 weeks of
VAD decreases hippocampal neurogenesis, based on the numbers
of doublecortin-IR cells, and impairs spatial memory. These effects
are reversed by 4 weeks RA treatment.Furthermore, the restoration
of neurogenesis in VAD rats receiving RA treatment may in part be
relatedto up-regulationof retinoid-mediatedmolecular events, such
as the expression of the neurotrophin receptor TrkA.
We have shown that a VAD starting at weaning for 11 weeks did
not affect cell proliferation or the number of immature DCX
neurons when compared to control animals fed with a control diet
containing 5 IU retinol/g. Although serum retinol concentration, a
good indicator of vitamin A depletion, was significantly reduced, 11
weeks of diet was not sufficient to entirely deplete vitamin A
reservoir. This may explain the lack of effects on neurogenesis. This
result is in line with a previous study failing to observe a down-
regulation of RA-regulated genes within the hippocampus after a
short-termVAD(10weeks).Thattreatment,however,wassufficient
todecrease targetgene expressioninthe striatum[47].Incontrast,a
total depletion in serum retinol levels was observed after 14 weeks of
VAD(undetectablelevels).In this condition,we observeda decrease
incellproliferation and neurogenesis,asindicated bychangesinKI-
67 and DCX. This cytoplasmic protein is expressed by immature
neurons until they are 2–3 weeks old [40,41]. This developmental
time course, together with the 3 weeks delay necessary to observe a
decrease in DCX expression, suggests that the loss in immature
neurons results from an initial reduction in cell proliferation
occurring after the 11
th week of the VAD. Furthermore, VAD did
not seem to influence cell survival and differentiation. Indeed, the
survival of the cells born during the 10
th week of the VAD was not
impaired by additional 4 weeks of VAD, and the rate of survival
calculated in the same animals was not influenced by VAD. These
results contrast with those obtained recently, which show that VAD
administration from birth to 18 weeks of age failed to influence cell
proliferation while decreasing the survival and neuronal differen-
tiation of 3-week-old newly born cells [34]. The discrepancy
between the two studies may be related to differences in the animal
models. Indeed, in our study VAD was begun at weaning sparing
the early postnatal period whereas in the other study VAD was
began from birth. Differences in the duration of the vitamin A
deficient diet, and/or the time and method of RA supplementation
could also be involved.
Administration of RA (all-trans) to control rats for one or four
weeks did not modify neurogenesis. This contrasts with a previous
study showing that 13–cis-RA (anti-acne drug accutane) decreases
hippocampal neurogenesis in mice after 3 weeks of treatment [33].
Species differences in RA sensitivity and/or differences in the dose
of RA (150 mg vs 1 mg/kg/day) may explain the discrepancy
between these studies. Furthermore, because 13-cis RA has a low
affinity for RA receptors [48], the biological effects of these two
retinoic acid isomers may also differ.
More importantly, we found that RA was very potent in animals
with a RA hypo-signaling. First, it increased cell proliferation in
rats submitted to 11 weeks of VAD. Second, the supernumerary
cells generated in animals submitted to 11 weeks of VAD survived
and differentiated into neurons. Third, 4 weeks RA treatment to
14-week-old VAD rats increased cell proliferation and neurogen-
esis (i.e. number of DCX neurons and number of BrdU-NeuN co-
labeled neurons) above the control values. This overcompensation
might be related to a hypersensitivity of the molecular cascade
downstream the RA receptors (see below). In line with these
results, neonatal administration of an inhibitor of RA synthesis
(disulfiram) decreased cell proliferation in the subventricular zone
(SVZ), another neurogenic zone [31].
RA may regulate neurogenesis via several mechanisms. RA
might directly regulate neurogenesis by acting through its specific
nuclear receptors, the nuclear retinoic acid receptors (RARa,b,c)
and the retinoid X receptors (RXRa,b,c) [49–51], which are
expressed by immature dividing cells. In the adult SVZ, a
population of slowly dividing cells, the stem cells, has been shown
to be activated by RA [52]. Consistent with that finding, SVZ–
derived neurospheres expressing RARa,b,c receptors also depend
Figure 5. Effects of 14 weeks of vitamin A deficiency and RA treatment on spatial memory in the water maze. Spatial learning as shown
by the evolution of the mean distance (A) covered by rats or the latency (B) to find the hidden platform. In the insert are shown the mean distance or
the mean latency over the seven days of training. (C) Percentage of time spent by rats in the target quadrant; the dotted line corresponds to chance
level. VAD-induced spatial memory deficits are rescued by RA treatment. ##p,0.01, ###p,0.001 when compared to C+RA, up,0.05, uuup,0.001
when compared to controls, *p,0.05, ***p,0.001 when compared to VAD+RA.
doi:10.1371/journal.pone.0003487.g005
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neurogenesis by activating the proliferation of stem cells present in
this area. Moreover, RA has been shown to regulate neurogenesis
in vitro by activating neurogenesis-related gene expression,
including neurotrophin receptors [30]. Thus, the effects of VAD
and RA were examined on TrkA, a receptor for Nerve Growth
Factor (NGF) [42,45,46], and TrkB, a receptor for Brain Derived
Neurotrophic Factor [43,44] known to be expressed in the HF
[53,54]. Our results showed that VAD tended to reduce
hippocampal TrkA expression (difference that was statistically
significant when comparing TrkA expression between control and
VAD groups using a t Test, p=0.028). This effect was reversed by
RA administration. In contrast, TrkB was not modified by VAD
or RA. This finding suggested that RA, acting by increasing
hippocampal expression of TrkA receptors, can potentiate NGF/
TrkA signaling. This signaling may sustain the RA-induced
increase in neurogenesis in VAD rats. Another non-exclusive
possibility involves an indirect action via the septo-hippocampal
cholinergic pathway. VAD reduces the activity of this pathway
[18,55], known to be under the control of NGF [56,57].
Furthermore, immunolesion of this pathway decreases hippocam-
pal neurogenesis [58,59], whereas chronic treatment with NGF
increases hippocampal neurogenesis [60]. Thus, it is possible that
VAD impairs neurogenesis via a downregulation of the septo-
hippocampal cholinergic pathway and that RA restores neuro-
genesis via an increased activity of these neurons.
Our results also demonstrated that VAD induced deficits in
spatial memory in the water maze. Memory deficits evidenced in
VAD rats did not result from visual alterations or motor
impairments, known to appear following long-term diet [61–63]
as they were able to find a visible platform. Furthermore, VAD
rats were able to swim at similar speeds as control rats. The decline
in spatial memory in VAD rats was fully restored by the RA
administration, suggesting that activation of retinoid signaling
through RA nuclear receptors is sufficient to alleviate the
symptoms. Previous studies have shown that VAD [18,19] or
age-related brain retinoid hyposignaling [20] impairs spatial
memory. More controversial are the effects of RA that can
alleviate in some cases [18,20] but not in all [19] retinoid
hyposignaling-induced memory deficits. Furthermore, chronic 13-
cis RA treatment of rats given a normal diet has been shown to
either induce spatial memory deficits [33] or to produce no effect
[64]. This discrepancy may be related to differences in subject age,
species, and treatment used. In one study, spatial learning was
impaired following a chronic RA treatment [33], a deficit probably
due to the non-physiological dose of RA used (1 mg/kg).
Altogether, the present results suggest that spatial memory
deficits observed after a hypoactivity of retinoid signaling could be
in part related to an alteration of hippocampal neurogenesis. This
contention is supported by the fact that RA treatment in VAD rats
restores both hippocampal neurogenesis and hippocampal-depen-
dent memory. Our VAD rats were profoundly impaired in the
acquisition of spatial memory and exhibited the same learning
curve as transgenic mice with ablation of adult-born hippocampal
neurons [65]. However, future studies are needed to confirm a
causal relationship between VAD-induced changes in neurogen-
esis and spatial memory. Our results also show that RA regulates
neurogenesis and memory function by activating the transcription
of TrkA receptors. However, we cannot exclude the possibility that
a change in retinoid signaling influences neurogenesis and
memory through a modification of synaptic plasticity. Indeed,
VAD results in a reversible loss of hippocampal CA1 long term
potentiation (LTP) and long term depression (LTD) [15].
Furthermore, age-related hypoactivity of retinoid signaling
pathway impairs CA1 LTP, an effect abrogated by the
normalization of retinoid signaling [20]. Thus, VAD-induced
changes in synaptic plasticity within the DG could alter
neurogenesis and spatial memory. This hypothesis is supported
by the observation that hippocampal neurogenesis is increased by
LTP [66]. However, controversial results have been obtained on
the link between neurogenesis and LTP [67,68] indicating that we
cannot exclude that RA signaling affects hippocampal functions
and neurogenesis through other mechanisms. Interestingly,
memory dysfunction in aged rats, associated with hippocampal
retinoid hyposignaling, is alleviated by RA-induced normalization
of this retinoid signaling pathway [20]. Given that memory
abilities have been related to hippocampal neurogenesis in aged
rats [69,70], this raises the issue as to whether RA-induced
improvement in memory function in aged subjects depend upon
an enhancement of neurogenesis.
Figure 6. Effects of 14 weeks of vitamin A deficiency and RA treatment on mRNA expression of neurotrophic receptors in the
hippocampus. (A) TrkA and (B) TrkB mRNA expression as quantified by Real Time-PCR. RA treatment compensated VAD-induced reduction in
hippocampal TrkA mRNA.**p,0.01 when compared to VAD+RA.
doi:10.1371/journal.pone.0003487.g006
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hippocampal plasticity and function. This is the first study showing
that RA treatment, can counteract the effects of vitamin A
deficiency on adult hippocampal neurogenesis disruption, one of
the plasticity mechanisms involved in hippocampal-dependent
spatial memory. Given the likely effects of RA treatment on
hippocampus plasticity and function, a number of important
future approaches arise from these results. In particular, the
involvement of retinoids as a valuable strategy for the treatment of
hippocampal-dependent disorders by promoting hippocampal
plasticity and neurogenesis should be investigated.
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